Nephrology Doctors in N Kansas City, MO Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Dr. James C Redington, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 410, N Kansas City, MO 64116 Phone: 816-474-9353    Fax: 816-474-3627

Dr. Suganthi Beeki, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suie 410, N Kansas City, MO 64116 Phone: 816-474-9353    Fax: 816-474-3627

Dr. Larry E Benson, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2790 Clay Edwards Dr, Suite 410, N Kansas City, MO 64116 Phone: 816-474-9353    Fax: 816-474-3627

News Archive

Study finds connection between obesity and sociodemographic, economic characteristics

Nearly 70 percent of the U.S. adult population meets the definition of overweight or obese, but a new study by University of Arkansas researchers shows the problem isn't randomly distributed across the country. Instead, obesity is concentrated in areas with social and demographic factors that create what researchers term an "ecology of disadvantage."

Genomic Health announces Medicare coverage for Oncotype DX prostate cancer test

Genomic Health, Inc. today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic technologies, has issued its final local coverage determination (LCD) approving coverage of the Oncotype DX prostate cancer test for qualified Medicare patients throughout the United States.

Osteoarthritis and rheumatoid arthritis have similar impacts on patients

Osteoarthritis has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis, and some may believe that it is part of a normal aging process requiring acceptance, not treatment.

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

Read more Medical News

› Verified 2 days ago